Hyperuricemia and Gout in Cyclosporin A-Treated Renal Transplant Recipients
Hyperuricemia and gout have been reported in patients receiving cyclosporin therapy for immunosuppression after organ transplantation.1–5 We evaluated the frequency and mechanism of hyperuricemia during cyclosporine A therapy in a group of patients who had received a renal transplant.
Unable to display preview. Download preview PDF.
- 4.J.P. VanHooff, K.M.L. Leunissen, and W. vandeStaak, Cyclosporin, uric acid, and the kidney, Lancet 1: 701 (1985).Google Scholar
- 5.J.S. Najarian, D.S. Fryd, M. Strand, D.M. Canafax, N.L. Ascher, W.D. Payne, R.L. Simmons, and D.E. Futherland, A single institution randomized prospective trial of cyclosporin versus azathioprine — antilymphocyte globulin for immunosuppression in renal allograft recipients, Ann. Sura. 201: 142 (1985).CrossRefGoogle Scholar
- 8.R. Bianchi, C. Vitali, A. Clerico, A. Pilo, L. Riente, L. Fusani, and G. Mariani, Uric acid metabolism in normal subjects and in gouty patients by Chromatographic measurementof 14C-uric acid in plasma and urine, Metabolism (1979).Google Scholar
- 9.B.M. Hall, D.J. Tiller, I. Hardie, J. Mahony, T. Mathew, G. Thatcher, P. Miach, N. Thomson, and A.G. RossSheil, Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporin, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisone withou;cyclosporine, N. Enal. J. Med. 318: 1499 (1988).CrossRefGoogle Scholar
- 11.S.L. Cohen, G. Boner, J.B. Rosenfeld, D. Shmuel, O. Sperling, A. Yusim, A. Todd-Pokropek, and Z. Shapira, The mechanism of hyperuricemia in cyclosporin-treated renal transplant recipients, Transplant Proc. 1829 (1987).Google Scholar